CN1312085A - Dermatosis treating medicine - Google Patents
Dermatosis treating medicine Download PDFInfo
- Publication number
- CN1312085A CN1312085A CN 00112737 CN00112737A CN1312085A CN 1312085 A CN1312085 A CN 1312085A CN 00112737 CN00112737 CN 00112737 CN 00112737 A CN00112737 A CN 00112737A CN 1312085 A CN1312085 A CN 1312085A
- Authority
- CN
- China
- Prior art keywords
- tinea
- skin
- examples
- medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 208000017520 skin disease Diseases 0.000 title claims description 5
- 206010048768 Dermatosis Diseases 0.000 title description 4
- 241000132012 Atractylodes Species 0.000 claims abstract description 4
- 235000012907 honey Nutrition 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 4
- 241000031023 Amana edulis Species 0.000 claims description 3
- 244000056139 Brassica cretica Species 0.000 claims description 3
- 235000003351 Brassica cretica Nutrition 0.000 claims description 3
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 3
- 241000258920 Chilopoda Species 0.000 claims description 3
- 241000931705 Cicada Species 0.000 claims description 3
- 244000111489 Gardenia augusta Species 0.000 claims description 3
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims description 3
- 241000237502 Ostreidae Species 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 3
- 241000405414 Rehmannia Species 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 3
- 240000006688 Telosma cordata Species 0.000 claims description 3
- 235000017352 Telosma cordata Nutrition 0.000 claims description 3
- 241000271897 Viperidae Species 0.000 claims description 3
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 3
- 235000010460 mustard Nutrition 0.000 claims description 3
- 235000020636 oyster Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims 1
- 208000002474 Tinea Diseases 0.000 abstract description 26
- 241000130764 Tinea Species 0.000 abstract description 18
- 201000004624 Dermatitis Diseases 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 10
- 208000003251 Pruritus Diseases 0.000 abstract description 9
- 201000004681 Psoriasis Diseases 0.000 abstract description 8
- 208000010668 atopic eczema Diseases 0.000 abstract description 8
- 206010005913 Body tinea Diseases 0.000 abstract description 6
- 241000721454 Pemphigus Species 0.000 abstract description 6
- 201000003875 tinea corporis Diseases 0.000 abstract description 6
- 201000010618 Tinea cruris Diseases 0.000 abstract description 5
- 201000004647 tinea pedis Diseases 0.000 abstract description 5
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 241000533849 Gleditsia Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000949456 Zanthoxylum Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000010903 husk Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 206010040943 Skin Ulcer Diseases 0.000 description 14
- 231100000019 skin ulcer Toxicity 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000001139 anti-pruritic effect Effects 0.000 description 5
- 239000003908 antipruritic agent Substances 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 206010067197 Tinea manuum Diseases 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- 241000271039 Agkistrodon Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- -1 PIKANGWANG Chemical compound 0.000 description 1
- 206010033474 Pain of skin Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 241001250596 Pleione Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The Chinese medicine mainly for curing various sore and tinea, including eczema, pruritus, pemphigus, psoriasis, tinae manuum, tinea pedis, tinea corporis and tinea cruris with specific effect is from 24 Chinese medicinal materials of gleditsia thorn, borneal, gardenia fruit rhubarb, red peony root, zanthoxylum husk, ovate atractylodes root and others and mixing them with honey.
Description
The present invention relates to treat dermopathic medicine, especially treat eczema, the medicine of pruritus, pemphigus, psoriasis, tinea manus and pedis, tinea corporis and tinea cruris disease.
Dermatosis is a kind of stubborn disease, and is comparatively common, and sickness rate height and shape disease are had, the cause of disease and symptom are also very complicated, often cause in various degree misery to the patient, thereby influence patient's physical and mental health, more examine and retort with challenging questions, treat thorny and be doctor's worries to grasp because of it.1), alleviate clinical symptoms modern department of dermatologry is the therapeutic purposes of the obstinate skin ulcer tinea of skin:; 2), reduce skin lesion, antipruritic, promotion skin recovery; 3), improve skin function and prevent the recurrence of skin ulcer tinea; 4), prevent that the skin ulcer tinea from stretching, infect and complication.At present, to control dermopathic medicine kind a lot of for oral administration and externally on the market, but all can not change the natural history of skin skin ulcer tinea and prevent the recurrence of skin ulcer tinea fully.As the external skin medicine: a bacterium tinea liquid, clotrimazole tinea liquid, miconazole ointment, PIKANGWANG ointment, econazole etc. go out, oral medicine is invalid to skin stubborn dermatitis as: XUEDU WAN, noxious dampness gel resin ball and blood poison gel resin ball etc., just general skin allergy is had alleviation.
It is investigated newly " a kind of oral medicine for the treatment of dermatodynia " application number: 98121810.5, publication number: CN1214261A, though this invention can be controlled various dermatosiss, its composition and composition of the present invention are different.
The objective of the invention is to overcome the defective of above-mentioned medicine, and a kind of various obstinate skin ulcer tinea, anti-inflammation detumescence of fundamentally effecting a radical cure is provided, and do not have the medicine of Drug resistance.
The object of the present invention is achieved like this:
The present invention is made by the bulk drug of following weight portion: spina gleditsiae 8～15 Borneolums 1～2 mountain Cape jasmine 12～15 Sichuan troops 3～6 radix paeoniae rubrathe, 8～14 pericarpium zanthoxylis, 3～6 bighead atractylodes rhizomes, 10～15 dandelions, 15～20 Chinese violets 12～20 are processed mustard fringe 8～15 calcined oyster shells 15～25 kuh-sengs 5～12 river nazes 5～10 Radix Angelicae Sinensis 12～18 Radixs Astragali 12～18 dried rhizome of rehmannia 15～25 and fall all 4～8 honeysuckles, 15～25 edible tulips, 10～15 cicada sloughs, 12～18 refined company 5～10 centipedes, 2～4 scorpios, 8～12 long-noded pit vipers, 20～30 honey 220～358
Compound method of the present invention is to be ground into smalls after above-mentioned 24 flavor Chinese herbal medicine are dried, and additional proportion is that 1: 1 Mel is made piece or ball, every (ball) heavy 6g.
The present invention is to be guidance with the Chinese medical theory, and prescription is reasonable, and the Chinese herbal medicine that is adopted has following effect:
Fructus Gardeniae, refined company: have clearing away heat-damp and promoting diuresis, detoxifcation, relieving restlessness treatment eczema; Radix Et Rhizoma Rhei, Radix Paeoniae Rubra: have removing heat from blood pathogenic fire purging, stasis-dispelling and pain-killing, broken heavily fortified point amasss, attacks the carbuncle skin ulcer; Spina Gleditsiae, Pseudobulbus Cremastrae Seu Pleiones: have expelling pus and toxin by strengthening QI, an eliminating carbuncle of invigorating blood circulation, eliminating stagnation master, furuncle is swollen; Radix Sophorae Flavescentis: have parasite killing, antipruritic, dampness, treatment malignant boil scabies; River Squama Manis: have that collateral dredging is sensible, parasite killing, control malignant boil, scabies; Radix Angelicae Sinensis, the Radix Astragali: have invigorate blood circulation, hemopoietic and blood, profit muscles and bones skin, the promoting pus discharge and tissue regeneration strengthening master carbuncle skin ulcer that relieves internal heat for a long time is persons particularly liable to develop skin infection's panacea, gets the reason of its " control wind and control blood earlier, the blood sector-style is from going out "; All, Fructus Zanthoxyli falls: have parasite killing, stagnation resolving, specially control the sore scabies; Scolopendra, Scorpio: can treating the poisonous disease with poisonous drugs, can detoxicating and resolving stagnation of pathogens, again can removing obstruction in the collateral to relieve pain, control sore swollen toxin scrofula tuberculosis; Agkistrodon: have row and not dry, it is antipruritic to search wind, the active kind stubborn dermatitis obstinate pyogenic sore of the skin skin pruritus of controlling; Concha Ostreae (calcined): hard masses softening and resolving, restrain the wart disease that disappears, long-pending piece; Flos Lonicerae: separate the dirty evil of pestilence, turbid pathogen and Yang Meizhu malignant boil; Periostracum Cicadae: the mercapto wind heat ends that skin is itched and furuncle toxic swelling skin ulcer; Borneol: can ward off all evilnesses, diffusing skin rheumatism.All medicine compatibilities, it is rigorous that rationally being referred to as the deficiency of YIN can mend, and the heat in blood energy dryly then can moisten clearly, and wind then can be dispelled, and is wet then can remove, and worm then can kill, and itches and then can end, and the stasis of blood then can disappear, and carbuncle then can be loose.It becomes wind dispelling antipruritic, removing dampness and detoxicating, the heat clearing away parasite killing, the eliminating carbuncle eliminating stagnation, the evacuation of pus pain relieving, dissipating blood stasis and blood, nourish blood, the merit of hemopoietic.Full medicine assistant is moisturized QI invigorating with Mel and is set upright, settling five organs various symptoms and signs of deficiency and be in harmonious proportion hundred medicines and the effect of controlling dermatosis chronic disease of gathering altogether.
Function of the present invention: wind dispelling is antipruritic, remove damp and clearing heat, detoxifcation parasite killing, eliminating carbuncle eliminating stagnation, evacuation of pus pain relieving, dissipating blood stasis and blood, strengthening spleen and nourishing blood, hemopoietic, speckle removing are dispelled black.
The present invention cures mainly: various obstinate skin ulcer tinea have as stubborn dermatitis: neck tinea, tinea corporis, tinea unguium, pityriasis, trick tinea, syphilis tinea, psoriasis, psoriasis, flat tinea, abdomen umbilicus ringworm, bad luck tinea, psoriasis, Flos Mume tinea, tinea versicolor etc.Obstinate pyogenic sore of the skin has: the swollen skin ulcer of syphilitic skin lesion, tinea alba, scrofula, face skin infection, crown malignant boil, measles sore, eczema of ear, aphtha, pemphigus, chieftain's skin ulcer, knee joint skin ulcer, the mashed tinea skin ulcer of husky wooden foot lever and eczema, anaphylaxis urticaria, pimple, macule etc. to whole skin redness, pain bleeding blister rot, serious symptom such as the long stream of yellow fluid.
Be clinical efficacy situation of the present invention below:
1, case and method (clinical data)
1.1, physical data: this organizes 250 routine patients all is through clinical, the traditional Chinese medical science is hoped, hears, asks, cuts dialectical and laboratory rhzomorph test diagnosis, eczema, pruritus, pemphigus that the inspection of dermatophytosis direct smear, cultivation inspection, pathogen inspection, cytoscopy, tuerculoderma are made a definite diagnosis, psoriasis, tinea corporis and tinea cruris, tinea manus and pedis.Wherein male 130 examples, women 120 examples, age 9-68 year, 32 years old mean age.Eczema 97 examples among the 250 routine patients, pruritus 32 examples, pemphigus 19 examples, psoriasis 23 examples, tinea manus and pedis 38 examples, tinea corporis and tinea cruris 41 examples.Year surplus the course of disease first quarter moon-20.
1.2, clinical manifestation: all patients all have skin pruritus in various degree, pain, scorching hot, grab scar, cicatrix, blood crusts, skin color and change skin lesion and general malaises such as decolouring or pigmentation.The some cases scaling of skin comes off, and erosion, ulcer, plays pustule, blister, pimple, macule, and chapped skin or atrophy are all stood prescription on individual diagnosis with agonizing.
1.3, go to a doctor before medicining condition: 250 routine patients take the present invention treat before equal multi-treatments, took greatly how long that dexamethasone, chlorphenamine, hismanal, itraconazole, noxious dampness are clear, XUEDU WAN, griseofulvin, mildew making sheet or inject calcium preparation and external miconazole, PIKANGWANG, clotrimazole, a bacterium of going out, dermatitis equality unsatisfactory curative effect or invalid and go to a doctor.
1.4, efficacy assessment standard
Effectively: medication 5 days, clinical symptom relief, partly transference cure; Produce effects: clinical symptoms obviously alleviates, most transference cure; Clinical recovery: symptom all disappears, and the patient does not have that any skin is itched, the sense of painful and discomfort, and drug withdrawal February, the state of an illness does not have recurrence, rebounds; Recovery from illness: clinical symptoms all disappears (or through pathogen inspection, the direct microscopy of rhzomorph or cultivation confirmation), and the drug withdrawal state of an illness in April does not have recurrence, does not have bounce-back.Invalid: medication 7 days, clinical symptoms do not have and alleviate, and do not have and improve.
1.5, Therapeutic Method and dosage
Be all to be the adult the minor except that 12 examples among the 250 routine patients, adult patient is all by each (6g) every day 3 times, and the minor is by each half block (3g) every day 3 times, ante cibum or swallow with eliminating cold for resuscitation water or Mel boiled water or chew clothes half an hour after meal.No longer add other medicines during the treatment.
2, therapeutic outcome
2.1 250 routine patients after 2-6 week treatment, 236 examples of fully recovering, cure rate reaches 94.4%, produce effects 12 examples, invalid 2 examples.Wherein: 97 routine eczema 2 week recovery from illness 69 examples, produce effects 28 examples, 4-5 week recovery from illness 28 examples, total cure rate 100%; 32 routine pruritus patient 2-4 week all cures, the smelting rate 100% that heals; Pemphigus patient 19 examples were all cured in January; All cure in the 22 routine 1-2 months in psoriasis 23 examples, 1 example is serious and have double disease failing to respond to any medical treatment to transfer because of skin lesion; Through 3-6 week treatment, 29 examples are fully recovered 9 routine produce effects, total effective rate 100% in tinea manus and pedis 38 examples; In tinea corporis and tinea cruris 41 examples through 5 week treatment back recoveries from illness, 36 examples, produce effects 4 examples, invalid 1 is routine because of there being severe complication to transfer from one hospital to another.
2.2, skin pruritus extinction time 1-5 days 195 examples, 5-10 days 53 examples.
2.3, scorching hot, the pain of skin, grab scar, numbness, general malaise extinction time 1-7 days 163 examples, 7-15 days 76 examples.
2.4, erosion, silver-colored bits, blood crusts, ulcer, pustule, blister, chap, atrophy skin improves time: 3-7 days 192 examples, 7-14 days 53 examples.
2.5, untoward reaction and toxic and side effects: after 250 routine patients take medicine of the present invention, do not have 1 example and tangible untoward reaction occurs, illustrate that the present invention has no side effect.
The below is further elaborated embodiments of the invention: bulk drug title embodiment 1 (weight portion) embodiment 2 (weight portion) embodiment 3 (weight portion) spina gleditsiae 8 12 15 Borneolums 122 mountain Cape jasmines 12 14 15 Sichuan troops 356 red spoon 8 10 14 pericarpium zanthoxylis 356 bighead atractylodes rhizomes 10 12 15 dandelions 15 17 20 Chinese violets 12 15 20 are processed mustard fringe 8 12 15 calcined oyster shells 15 20 25 kuh-sengs 5 10 12 river nazes 57 10 Radix Angelicae Sinensis 12 15 18 Radixs Astragali 12 15 18 dried rhizome of rehmannia 15 20 25 and fall all 468 honeysuckles, 15 20 25 edible tulips, 10 13 15 cicada sloughs, 12 15 18 refined company 57 10 centipedes, 234 scorpios, 8 10 12 long-noded pit vipers, 20 25 30 honey 220 280 358
Said herbal medicine dried respectively be ground into smalls altogether, add Mel and make piece or ball, the heavy 6g of every ball, airtight standby.
Usage and dosage: be grown up and obeyed three times in one day, one time one ball, children's all can take, and one day clothes of children's below nine years old, one piller divides secondary to take, and one month is a course of treatment.
Period in a medicine is avoided: hot, peppery, wine, raw meat, stimulating food, stimulation diet.
Attention: anemia of pregnant woman and adiposis patient are avoided clothes, have serious stomach patient to take with the Mel boiled water.
Claims (1)
- A kind of medicine for the treatment of skin disease is characterized in that it is to be made by the raw material of following weight part: spina gleditsiae 8～15 Borneolums 1～2 mountain Cape jasmine 12～15 Sichuan troops 36 radix paeoniae rubrathe, 8～14 pericarpium zanthoxylis, 3～6 bighead atractylodes rhizomes, 10～15 dandelions, 15～20 Chinese violets 12～20 are processed mustard fringe 8～15 and forge mountain, oyster 15～25 kuh-sengs, 5～12 river first 5～10 Radix Angelicae Sinensis 12～18 Radixs Astragali 12～18 dried rhizome of rehmannia 15～25 and fall all 4～8 honeysuckles, 15～25 edible tulips, 10～15 cicada sloughs, 12～18 refined company 5～10 centipedes, 24 scorpios, 8～12 long-noded pit vipers, 20～30 honey 220～358
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00112737 CN1312085A (en) | 2000-03-08 | 2000-03-08 | Dermatosis treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00112737 CN1312085A (en) | 2000-03-08 | 2000-03-08 | Dermatosis treating medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1312085A true CN1312085A (en) | 2001-09-12 |
Family
ID=4582576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00112737 Pending CN1312085A (en) | 2000-03-08 | 2000-03-08 | Dermatosis treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1312085A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102210804A (en) * | 2011-05-22 | 2011-10-12 | 杨晓陆 | Medicament for treating psoriasis |
| CN103495074A (en) * | 2013-08-26 | 2014-01-08 | 许其树 | Traditional Chinese medicine composition for treating favus of the scalp |
| CN103638176A (en) * | 2013-12-12 | 2014-03-19 | 苏振华 | Medicine for treating eczema and preparation method of medicine |
| CN104398724A (en) * | 2014-10-28 | 2015-03-11 | 山东瑞康生命科技有限公司 | Preparation method for traditional Chinese medicine preparation treating pemphigus |
| CN105250488A (en) * | 2015-11-15 | 2016-01-20 | 衡阳市金凤牲猪养殖专业合作社 | Drug for preventing and treating pig skin disease and preparation method thereof |
| CN107739671A (en) * | 2017-10-18 | 2018-02-27 | 洪雅县瓦屋山药业有限公司 | A kind of refined even medicated soap and preparation method thereof |
| DE112007001091B4 (en) | 2006-04-29 | 2019-02-21 | Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co.,Ltd. | A pharmaceutical formulation in the form of an ointment for the treatment of tinea of the feet and hands and preparation methods thereof |
-
2000
- 2000-03-08 CN CN 00112737 patent/CN1312085A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE112007001091B4 (en) | 2006-04-29 | 2019-02-21 | Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co.,Ltd. | A pharmaceutical formulation in the form of an ointment for the treatment of tinea of the feet and hands and preparation methods thereof |
| CN102210804A (en) * | 2011-05-22 | 2011-10-12 | 杨晓陆 | Medicament for treating psoriasis |
| CN103495074A (en) * | 2013-08-26 | 2014-01-08 | 许其树 | Traditional Chinese medicine composition for treating favus of the scalp |
| CN103638176A (en) * | 2013-12-12 | 2014-03-19 | 苏振华 | Medicine for treating eczema and preparation method of medicine |
| CN104398724A (en) * | 2014-10-28 | 2015-03-11 | 山东瑞康生命科技有限公司 | Preparation method for traditional Chinese medicine preparation treating pemphigus |
| CN105250488A (en) * | 2015-11-15 | 2016-01-20 | 衡阳市金凤牲猪养殖专业合作社 | Drug for preventing and treating pig skin disease and preparation method thereof |
| CN107739671A (en) * | 2017-10-18 | 2018-02-27 | 洪雅县瓦屋山药业有限公司 | A kind of refined even medicated soap and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100434107C (en) | Acne clearing decoction | |
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
| CN101040990A (en) | Chinese traditional medicine compound took orally for treating gout | |
| CN102861287A (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
| CN103142938A (en) | Plaster for treating traumatic injury and fracture | |
| CN1312085A (en) | Dermatosis treating medicine | |
| CN102028901B (en) | Traditional Chinese medicine for treating knee joint hypertrophic synovitis | |
| CN101036758A (en) | Chinese traditional medicine composition took orally for treating chronic superficial gastritis | |
| CN101041006A (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN100546640C (en) | A kind of Chinese medicine composition of orally taken for curing cyclomastopathy | |
| CN103585414B (en) | Pharmaceutical composition for treating sciatica and osteoporosis | |
| CN101940656A (en) | Medicament for treating hyperosteogeny | |
| CN101485844B (en) | Chinese medicinal composition for treating chronic gastritis | |
| CN1284593C (en) | Medicine for treating anaphylactoid purpura | |
| CN112043799A (en) | Oral medicine for treating gout and preparation method thereof | |
| CN1255143C (en) | Externally applied Chinese traditional medicinal wine and its preparing method | |
| CN1261123C (en) | Chinese medicine preparation pus drawing out plaster for treating pasteur cystic, furuncle, furunculosis and carbuncle | |
| CN105193912A (en) | Traditional Chinese medicine composition for treating acute mastitis and preparation method of traditional Chinese medicine composition | |
| CN101040979A (en) | Chinese traditional medicine compound took orally for treating protrusion of lumbar intervertebral disc | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN102114225A (en) | Traditional Chinese medicine for treating gout of diabetes patient | |
| CN101129716A (en) | Orally taken Chinese medicine for treating psoriasis | |
| CN1380082A (en) | Chinese medicine for curing female chronic inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |